Soft-tissue reconstruction company Tela Bio (NSDQ:TELA) announced the appointment of Dr. Bruce Freedman as VP of clinical development. Freedman has practiced 32 years as a general surgeon specializing in hernia repair and abdominal wall reconstruction. He joined Tela Bio after having used its OviTex material in his practice. The Malvern, Penn.-based company’s tech platform is […]
Tela Bio
FDA clears Tela Bio’s Restella soft tissue bioscaffolds
Tela Bio said yesterday that it won FDA 510(k) clearance for its Restella reconstructive bioscaffolds, now cleared for use in reinforcing soft tissue in patients requiring soft tissue repair or reinforcement during plastic or reconstructive procedures. The Malvern, Penn.-based company’s tech platform is based on interwoven polymer through layers of biologic tissue in a patented pattern […]
Tela Bio, Aroa Biosurgery win FDA nod for large-size OviTex bioscaffolds
Tela Bio and its partner Aroa Biosurgery said yesterday that it won FDA 510(k) clearance for large-size OviTex reinforced bioscaffolds intended for soft tissue repair. The OviTex RBS devices are surgical implants with integrated biologic and synthetic materials to allow the movement of fluid and cells through the product, Malvern, Penn.-based Tela Bio said. With […]
Former Rotation Medical CEO Shadan joins Miach Ortho | Personnel Moves – January 3, 2019
Early stage medtech firm Miach Orthopaedics said today that it named former Rotation Medical CEO and medtech vet Martha Shadan as its new prez and chief executive officer. Shadan has held numerous leadership positions at medtech firms, including Zimmer Biomet (NYSE:ZBH), Covidien, Bristol Myers Squibb and Merck, Westborough, Mass.-based Miach said. Prior to joining Miach, Shadan […]
Tela Bio raises more than $2 million
Regenerative surgical implants company Tela Bio has brought in more than $2 million in investments, according to a recent U.S. Securities and Exchange Commission filing. The Malvern, Pa.–based company had sought to raise a total $3 million, according to the SEC Form D filed Dec. 4. Get the full story on our sister site Drug […]
Tela Bio, Aroa Biosurgery win CE Mark for OviTex bioscaffolds
Tela Bio said today that its partner Aroa Biosurgery won CE Mark approval in the European Union for its OviTex Reinforced BioScaffold, which Tela Bio will commercially launch in the region. Malvern, Penn.-based Tela Bio said that is has offered the OviTex RBS for ventral hernia repairs and abdominal wall reconstruction procedures in the US since July […]
Tela Bio lands $1m investment for surgical implants
Privately-held Tela Bio said this week that it landed a $1 million investment from ProMedica, a not-for-profit healthcare group serving northwest Ohio and southern Michigan. According to the deal, Tela Bio and ProMedica Innovations Venture Fund plan to strike a strategic relationship to educate surgical specialists at the ProMedica Hernia Center using Tela Bio’s regenerative surgical implants. […]
Pacira to invest up to $25m in surgical reconstruction company
Pacira Pharmaceuticals (NSDQ:PCRX) plans to invest up to $25 million in privately-held surgical reconstruction company Tela Bio, the company said today. Pennsylvania-based Tela Bio has a portfolio of reinforced bioscaffold products, called OviTex, which combine biologic and synthetic materials in an embroidered implant that allows fluid and cells to move freely through the device. The implants […]
Tela Bio touts data for OviTex hernia repair bioscaffold
Tela Bio touted data this week for its OviTex reinforced bioscaffold used for hernia repair and abdominal wall reconstruction. The device combines biologic material and polymer, allowing for free movement of fluid and cells through the mesh. Tela Bio’s chief medical officer is slated to present initial feedback from surgeons using the device since it won FDA […]
Tela Bio launches post-clinical OviTex ventral hernia repair study
Tela Bio said today it initiated a post-market clinical study of its OviTex reinforced bioscaffold designed for soft tissue repair, enrolling the 1st patient at La Jolla, Calif.’s Scripps Clinic. The Ovitex reinforced bioscaffolds are designed for hernia repair or abdominal wall reconstructions, Tela Bio said. The scaffolds are designed with either permanent polymer or resorbable polymers, […]
Tela Bio raises $7.4m
Tela Bio raised $7.4 million in a new round of equity financing, according to an SEC filing posted this week. The company produces Ovitex reinforced bioscaffolds designed for hernia repair or abdominal wall reconstructions. The scaffolds are designed with either permanent polymer or resorbable polymers, and a re a mix of biologic and synthetic materials. Money […]